TrianglePUBLICATIONS · 21600759
Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Eur J Cancer
- Publication date
- 2011 Jul
- First author
- Patel PM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Patel PM
- type
- Author
- name
- Suciu S
- type
- Author
- name
- Mortier L
- type
- Author
- name
- Kruit WH
- type
- Author
- name
- Robert C
- type
- Author
- name
- Schadendorf D
- type
- Author
- name
- Trefzer U
- type
- Author
- name
- Punt CJ
- type
- Author
- name
- Dummer R
- type
- Author
- name
- Davidson N
- type
- Author
- name
- Becker J
- type
- Author
- name
- Conry R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Patel PM
- type
- Author
- name
- Suciu S
- type
- Author
- name
- Mortier L
- type
- Author
- name
- Kruit WH
- type
- Author
- name
- Robert C
- type
- Author
- name
- Schadendorf D
- type
- Author
- name
- Trefzer U
- type
- Author
- name
- Punt CJ
- type
- Author
- name
- Dummer R
- type
- Author
- name
- Davidson N
- type
- Author
- name
- Becker J
- type
- Author
- name
- Conry R
- type
- Author
- bibliography ids
- nci-bib-13ced08aa18b8aac18a27ab8
- book metadata
- content sha256
- 8d0f85a06dc60239c7ce552dfda61cf54b0db0a504c86c3d781fe4ec143aa641
- document type
- citation
- dois
- 10.1016/j.ejca.2011.04.030
- electronic publication date
- display
- 2011 May 18
- precision
- day
- year
- 2011
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:21600759
- immutable id
- pubmed:21600759@8d0f85a06dc60239c7ce552dfda61cf54b0db0a504c86c3d781fe4ec143aa641
- journal
- abbreviation
- Eur J Cancer
- issn electronic
- 1879-0852
- issn print
- 0959-8049
- issue
- 10
- name
- European journal of cancer (Oxford, England : 1990)
- nlm unique id
- 9005373
- pages
- 1476-83
- volume
- 47
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 21600759
- provenance
- batch id
- a366a1bc8ed89d8d7ca5
- provider
- NCBI PubMed ESummary
- record sha256
- 44132cdbb0eef70891931935120f3ad96b05cbb368e74ada36135db97c7f98cf
- response sha256
- c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
- retrieved at
- 2026-09-09T23:46:40.540025+00:00
- publication date
- display
- 2011 Jul
- precision
- month
- year
- 2011
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032).
Preserved source evidence · Not medical advice